Multiple T-cell responses to human immunodeficiency virus type 1 are enhanced by dendritic cells

Clinical and Vaccine Immunology

Volumn 16, Issue 10, 2009, Pages 1504-1516

  Huang, Xiao Li ^a   Fan, Zheng ^a   Borowski, LuAnn ^a   Rinaldo, Charles R ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; INTERLEUKIN 2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NEF PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DENDRITIC CELLS; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA; MOLECULAR SEQUENCE DATA; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES;

EID: 70349667814     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00104-09     Document Type: Article

References (54)

1. Addo, M. M., R. Draenert, A. Rathod, C. L. Verrill, B. T. Davis, R. T. Gandhi, G. K. Robbins, N. O. Basgoz, D. R. Stone, D. E. Cohen, M. N. Johnston, T. Flynn, A. G. Wurcel, E. S. Rosenberg, M. Altfeld, and B. D. Walker. 2007. Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection. PLoS One 2:e321.
2. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
3. Beattie, T., R. Kaul, T. Rostron, T. Dong, P. Easterbrook, W. Jaoko, J. Kimani, F. Plummer, A. McMichael, and S. Rowland-Jones. 2004. Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes. AIDS 18:1595-1598. (Pubitemid 39037485)
4. Benito, J. M., M. Lopez, and V. Soriano. 2004. The role of CD8+ T-cell response in HIV infection. AIDS Rev. 6:79-88. (Pubitemid 39149446)
5. Betts, M. R., M. C. Nason, S. M. West, S. C. De Rosa, S. A. Migueles, J. Abraham, M. M. Lederman, J. M. Benito, P. A. Goepfert, M. Connors, M. Roederer, and R. A. Koup. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107:4781-4789.
6. Binley, J. M., D. S. Schiller, G. M. Ortiz, A. Hurley, D. F. Nixon, M. M. Markowitz, and J. P. Moore. 2000. The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy. J. Infect. Dis. 181:1249-1263.
7. Ching, N., O. O. Yang, J. G. Deville, K. Nielsen-Saines, B. J. Ank, M. S. Sim, and Y. J. Bryson. 2007. Pediatric HIV-1-specific cytotoxic T-lymphocyte responses suggesting ongoing viral replication despite combination antiretroviral therapy. Pediatr. Res. 61:692-697.
8. Currier, J. R., E. G. Kuta, E. Turk, L. B. Earhart, L. Loomis-Price, S. Janetzki, G. Ferrari, D. L. Birx, and J. H. Cox. 2002. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J. Immunol. Methods 260:157-172.
9. Currier, J. R., U. Visawapoka, S. Tovanabutra, C. J. Mason, D. L. Birx, F. E. McCutchan, and J. H. Cox. 2006. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response. BMC Immunol. 7:8.
10. Deeks, S. G., and B. D. Walker. 2007. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 27:406-416.
11. De Rosa, S. C., F. X. Lu, J. Yu, S. P. Perfetto, J. Falloon, S. Moser, T. G. Evans, R. Koup, C. J. Miller, and M. Roederer. 2004. Vaccination in humans generates broad T cell cytokine responses. J. Immunol. 173:5372-5380.
12. Dieckmann, D., E. S. Schultz, B. Ring, P. Chames, G. Held, H. R. Hoogenboom, and G. Schuler. 2005. Optimizing the exogenous antigen loading of monocyte-derived dendritic cells. Int. Immunol. 17:621-635.
13. Draenert, R., M. Altfeld, C. Brander, N. Basgoz, C. Corcoran, A. G. Wurcel, D. R. Stone, S. A. Kalams, A. Trocha, M. M. Addo, P. J. Goulder, and B. D. Walker. 2003. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. J. Immunol. Methods 275:19-29. (Pubitemid 36351539)
14. Dubey, S., J. Clair, T. M. Fu, L. Guan, R. Long, R. Mogg, K. Anderson, K. B. Collins, C. Gaunt, V. R. Fernandez, L. Zhu, L. Kierstead, S. Thaler, S. B. Gupta, W. Straus, D. Mehrotra, T. W. Tobery, D. R. Casimiro, and J. W. Shiver. 2007. Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay. J. Acquir. Immune Defic. Syndr. 45:20-27.
15. Fan, Z., X. L. Huang, P. Kalinski, S. Young, and C. R. Rinaldo, Jr. 2007. Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection. Clin. VaccineImmunol. 14:1127-1137.
16. Ferre, A. L., P. W. Hunt, J. W. Critchfield, D. H. Young, M. M. Morris, J. C. Garcia, R. B. Pollard, H. F. Yee, Jr., J. N. Martin, S. G. Deeks, and B. L. Shacklett. 2009. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood 113:3978-3989.
17. Graham, B. S., R. A. Koup, M. Roederer, R. T. Bailer, M. E. Enama, Z. Moodie, J. E. Martin, M. M. McCluskey, B. K. Chakrabarti, L. Lamoreaux, C. A. Andrews, P. L. Gomez, J. R. Mascola, and G. J. Nabel. 2006. Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine. J. Infect. Dis. 194:1650-1660.
18. Harari, A., and G. Pantaleo. 2008. HIV-1-specific immune response. Adv. Pharmacol. 56:75-92.
19. Huang, K. H., M. R. Loutfy, C. M. Tsoukas, and N. F. Bernard. 2008. Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption. BMC Infect. Dis. 8:59.
20. Huang, X. L., Z. Fan, L. Borowski, and C. R. Rinaldo. 2008. Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8(+) T cell immunity. J. Leukoc. Biol. 83:1530-1540.
21. Huang, X. L., Z. Fan, B. A. Colleton, R. Buchli, H. Li, W. H. Hildebrand, and C. R. Rinaldo, Jr. 2005. Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons. J. Virol. 79:3052-3062.
22. Hunig, T. 2007. Manipulation of regulatory T-cell number and function with CD28-specific monoclonal antibodies. Adv. Immunol. 95:111-148.
23. Kan-Mitchell, J., B. Bisikirska, F. Wong-Staal, K. L. Schaubert, M. Bajcz, and M. Bereta. 2004. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope. J. Immunol. 172:5249-5261. (Pubitemid 38542022)
24. Kapogiannis, B. G., S. L. Henderson, P. Nigam, S. Sharma, L. Chennareddi, J. G. Herndon, H. L. Robinson, and R. R. Amara. 2006. Defective IL-2 production by HIV-1-specific CD4 and CD8 T cells in an adolescent/young adult cohort. AIDS Res. Hum. Retrovir. 22:272-282.
25. Karlsson, A. C., J. N. Martin, S. R. Younger, B. M. Bredt, L. Epling, R. Ronquillo, A. Varma, S. G. Deeks, J. M. McCune, D. F. Nixon, and E. Sinclair. 2003. Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells. J. Immunol. Methods 283:141-153. (Pubitemid 37501065)
26. Kern, F., N. Faulhaber, C. Frommel, E. Khatamzas, S. Prosch, C. Schonemann, I. Kretzschmar, R. Volkmer-Engert, H. D. Volk, and P. Reinke. 2000. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur. J. Immunol. 30:1676-1682.
27. Kiecker, F., M. Streitz, B. Ay, G. Cherepnev, H. D. Volk, R. Volkmer-Engert, and F. Kern. 2004. Analysis of antigen-specific T-cell responses with synthetic peptides - what kind of peptide for which purpose? Hum. Immunol. 65:523-536. (Pubitemid 38686777)
28. Lacabaratz-Porret, C., J. P. Viard, C. Goujard, Y. Levy, A. Rodallec, C. Deveau, A. Venet, and M. Sinet. 2004. Presence of HIV-specific CD4+ T-cell responses in HIV-infected subjects with sustained virologic control after highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 36:594-599.
29. Lamoreaux, L., M. Roederer, and R. Koup. 2006. Intracellular cytokine optimization and standard operating procedure. Nat. Protoc. 1:1507-1516.
30. Lange, C. G., M. M. Lederman, J. S. Madero, K. Medvik, R. Asaad, C. Pacheko, C. Carranza, and H. Valdez. 2002. Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection. J. Acquir. Immune. Defic. Syndr. 30:33-40.
31. Maecker, H. T., H. S. Dunn, M. A. Suni, E. Khatamzas, C. J. Pitcher, T. Bunde, N. Persaud, W. Trigona, T. M. Fu, E. Sinclair, B. M. Bredt, J. M. McCune, V. C. Maino, F. Kern, and L. J. Picker. 2001. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J. Immunol. Methods 255:27-40.
32. Meddows-Taylor, S., S. Shalekoff, L. Kuhn, G. E. Gray, and C. T. Tiemessen. 2007. Development of a whole blood intracellular cytokine staining assay for mapping CD4(+) and CD8(+) T-cell responses across the HIV-1 genome. J. Virol. Methods 144:115-121.
33. Migueles, S. A., A. C. Laborico, W. L. Shupert, M. S. Sabbaghian, R. Rabin, C. W. Hallahan, D. Van Baarle, S. Kostense, F. Miedema, M. McLaughlin, L. Ehler, J. Metcalf, S. Liu, and M. Connors. 2002. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3:1061-1068.
34. Mwau, M., A. J. McMichael, and T. Hanke. 2002. Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines. AIDS Res. Hum. Retrovir. 18:611-618.
35. Newton, P. J., I. V. Weller, I. G. Williams, R. F. Miller, A. Copas, R. S. Tedder, D. R. Katz, and B. M. Chain. 2006. Monocyte derived dendritic cells from HIV-1 infected individuals partially reconstitute CD4 T-cell responses. AIDS 20:171-180.
36. Nomura, L. E., J. M. Walker, and H. T. Maecker. 2000. Optimization of whole blood antigen-specific cytokine assays for CD4(+) T cells. Cytometry 40:60-68.
37. Owen, R. E., E. Sinclair, B. Emu, J. W. Heitman, D. F. Hirschkorn, C. L. Epling, Q. X. Tan, B. Custer, J. M. Harris, M. A. Jacobson, J. M. McCune, J. N. Martin, F. M. Hecht, S. G. Deeks, and P. J. Norris. 2007. Loss of T cell responses following long-term cryopreservation. J. Immunol. Methods 326:93-115. (Pubitemid 47361201)
38. Palmer, B. E., E. Boritz, N. Blyveis, and C. C. Wilson. 2002. Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4+ T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication. J. Virol. 76:5925-5936.
39. Piacentini, L., C. Fenizia, V. Naddeo, and M. Clerici. 2008. Not just sheer luck! Immune correlates of protection against HIV-1 infection. Vaccine 26:3002-3007.
40. Piguet, V., and R. M. Steinman. 2007. The interaction of HIV with dendritic cells: outcomes and pathways. Trends Immunol. 28:503-510. (Pubitemid 350087807)
41. Rehr, M., J. Cahenzli, A. Haas, D. A. Price, E. Gostick, M. Huber, U. Karrer, and A. Oxenius. 2008. Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy. J. Virol. 82:3391-3404.
42. Rinaldo, C. R. 2009. Dendritic cell-based human immunodeficiency virus vaccine. J. Intern. Med. 265:138-158.
43. Rock, K. L., I. A. York, T. Saric, and A. L. Goldberg. 2002. Protein degradation and the generation of MHC class I-presented peptides. Adv. Immunol. 80:1-70.
44. Roederer, M., J. M. Brenchley, M. R. Betts, and S. C. De Rosa. 2004. Flow cytometric analysis of vaccine responses: how many colors are enough? Clin. Immunol. 110:199-205. (Pubitemid 38402000)
45. Russell, N. D., M. G. Hudgens, R. Ha, C. Havenar-Daughton, and M. J. McElrath. 2003. Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity. J. Infect. Dis. 187:226-242.
46. Sercarz, E. E., and E. Maverakis. 2003. MHC-guided processing: binding of large antigen fragments. Nat. Rev. Immunol. 3:621-629.
47. Teixeira, L., H. Valdez, J. M. McCune, R. A. Koup, A. D. Badley, M. K. Hellerstein, L. A. Napolitano, D. C. Douek, G. Mbisa, S. Deeks, J. M. Harris, J. D. Barbour, B. H. Gross, I. R. Francis, R. Halvorsen, R. Asaad, and M. M. Lederman. 2001. Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS 15:1749-1756. (Pubitemid 32939234)
48. Tobery, T. W., and M. J. Caulfield. 2004. Identification of T-cell epitopes using ELISpot and peptide pool arrays. Methods Mol. Med. 94:121-132.
49. Tobery, T. W., S. A. Dubey, K. Anderson, D. C. Freed, K. S. Cox, J. Lin, M. T. Prokop, K. J. Sykes, R. Mogg, D. V. Mehrotra, T. M. Fu, D. R. Casimiro, and J. W. Shiver. 2006. A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV type 1 gag vaccinated human subjects. AIDS Res. Hum. Retrovir. 22:1081-1090.
50. Varela-Rohena, A., P. E. Molloy, S. M. Dunn, Y. Li, M. M. Suhoski, R. G. Carroll, A. Milicic, T. Mahon, D. H. Sutton, B. Laugel, R. Moysey, B. J. Cameron, A. Vuidepot, M. A. Purbhoo, D. K. Cole, R. E. Phillips, C. H. June, B. K. Jakobsen, A. K. Sewell, and J. L. Riley. 2008. Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nat. Med. 14:1390-1395.
51. Vasan, S., S. J. Schlesinger, and G. Arrode. 2007. T cell immune responses to HIV-1. Front. Biosci. 12:2330-2343.
52. Waldrop, S. L., K. A. Davis, V. C. Maino, and L. J. Picker. 1998. Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis. J. Immunol. 161:5284-5295.
53. Younes, S. A., B. Yassine-Diab, A. R. Dumont, M. R. Boulassel, Z. Grossman, J. P. Routy, and R. P. Sekaly. 2003. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J. Exp. Med. 198:1909-1922.
54. Zehn, D., C. J. Cohen, Y. Reiter, and P. Walden. 2006. Efficiency of peptide presentation by dendritic cells compared with other cell types: implications for cross-priming. Int. Immunol. 18:1647-1654.